Viewing data from:

ERYTHROMYCIN ETHYLSUCCINATE

ANDA

ERYTHROMYCIN ETHYLSUCCINATE | A211991 | PH HEALTH LTD

2 strengths0 unique patents0 unique exclusivities

API Supply Chain6 active DMFs9 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

ABBVIE INCERYTHROMYCIN ETHYLSUCCINATE

DMF 134431998

ERCROS SAERYTHROMYCIN ETHYLSUCCINATE

DMF 136541998

ALEMBIC PHARMACEUTICALS LTDERYTHROMYCIN ETHYLSUCCINATE USP

DMF 314512017

SM BIOMED SDN BHDERYTHROMYCIN ETHYLSUCCINATE USP

DMF 317542017

CENTURY PHARMACEUTICALS LTDERYTHROMYCIN ETHYLSUCCINATE USP

DMF 345812020

SOLARA ACTIVE PHARMA SCIENCES LTDERYTHROMYCIN ETHYLSUCCINATE USP

DMF 350462020

ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIVInactiveERYTHROMYCIN ETHYLSUCCINATE

DMF 132931998

ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIVInactiveERYTHROMYCIN ETHYLSUCCINATE

DMF 135111998

ARCHIFAR LABInactiveERYTHROMYCIN ETHYLSUCCINATE

DMF 136001998

POLFAInactiveERYTHROMYCIN ETHYLSUCCINATE

DMF 135801998

DSM ANDENO GMBHInactiveERYTHROMYCIN ETHYLSUCCINATE

DMF 135811998

GIST-BROCADES NV PHARMACEUTICALSInactiveERYTHROMYCIN ETHYLSUCCINATE

DMF 135831998

COMPANHIA INDUSTRIAL PRODUTORA DE ANTIBIOTICOS SARLInactiveERYTHROMYCIN ETHYLSUCCINATE

DMF 135891998

FERMIC SA DE CVInactiveERYTHROMYCIN ETHYLSUCCINATE

DMF 137111998

SANDOZ INDUSTRIAL PRODUCTS SPAInactiveERYTHROMYCIN ETHYLSUCCINATE

DMF 157892001

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 3, 2019	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — EQ 200MG BASE/5ML

0 patents0 exclusivities▴

GRANULE;ORAL | Approved: Oct 23, 2019

No patent or exclusivity listings for this strength.

#002 — EQ 400MG BASE/5ML

0 patents0 exclusivities▾

GRANULE;ORAL | Approved: Oct 23, 2019